Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for

Bishwajit Kundu1, Nilesh R Maiti, Eric M Jones

  • 1Department of Physiology and Biophysics, Case Western Reserve University, 3109 Adelbert Road, Cleveland, OH 44106, USA.

Insights

The Y145Stop mutation in human prion protein (PrP) causes disease. This study shows the Y145Stop PrP fragment spontaneously forms amyloid fibrils, with residues 138-141 being critical for this process.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • The Tyr to Stop codon mutation at position 145 (Y145Stop) in human prion protein (PrP) is linked to Gerstmann-Straussler-Scheinker-like disease.
  • This mutation leads to extensive amyloid deposits in the brain, a hallmark of prion diseases.

Purpose of the Study:

  • To investigate the spontaneous conversion of the Y145Stop PrP variant (huPrP23-144) into amyloid fibrils.
  • To identify the specific region within huPrP23-144 essential for amyloid fibril formation.

Main Methods:

  • Recombinant polypeptide expression and purification of huPrP23-144 and its fragments.
  • Characterization of fibril formation using protein concentration-dependent assays, atomic force microscopy (AFM), and Fourier-transform infrared (FTIR) spectroscopy.
  • Systematic deletion analysis of PrP fragments to pinpoint critical regions for amyloidogenesis.

Main Results:

  • huPrP23-144 spontaneously converts from a disordered monomeric state to amyloid fibrils via nucleation-dependent polymerization.
  • AFM revealed periodicity in fibrils, and FTIR confirmed the formation of beta-sheet structures, distinct from shorter model peptides.
  • Residues 138-141 were identified as essential for huPrP23-144 self-seeded assembly into amyloid fibrils.

Conclusions:

  • The Y145Stop PrP fragment possesses intrinsic properties enabling spontaneous amyloid formation.
  • The 138-141 region of PrP is critical for the conformational conversion and self-assembly into amyloid fibrils associated with this disease mutation.
  • Findings provide insights into the molecular mechanisms underlying prion protein misfolding and aggregation in disease.

Related Concept Videos

Protein Folding01:22

Protein Folding

Overview
Protein Folding01:22

Protein Folding

Overview
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...